Target intelligence / Profile preview

Mitochondrially encoded NADH dehydrogenase 1 pseudogene

Molecular classification
Other (Pseudogene; not an enzyme, receptor, transporter, ion channel, etc.)
01

Overview

Mitochondrially encoded NADH dehydrogenase 1 pseudogene (ENSG00000287800) is a non-functional genomic element derived from the **MT-ND1** gene, which encodes a core subunit of mitochondrial complex I, the NADH:ubiquinone oxidoreductase responsible for catalyzing electron transfer from NADH to ubiquinone in the respiratory chain[1][6]. Pseudogenes like ENSG00000287800 do not code for functional proteins; instead, they may contribute to regulation of their parental gene through mechanisms such as non-coding RNA transcription, epigenetic modification, or gene expression modulation, but do not play a canonical role in mitochondrial electron transport or human disease directly[3][4]. Their presence is sometimes relevant in genomic studies or as regulatory elements, but ENSG00000287800 is not a therapeutic, diagnostic, or molecular target in a conventional sense[1][3]. Key points: - This gene is a **pseudogene** of MT-ND1, not the functionally active (protein-coding) gene. - It is **not a therapeutic target** and should not be confused with NADH dehydrogenase 1 itself, which is a bona fide enzyme and sometimes a disease biomarker[6]. - It may have roles in the **epigenetic regulation** or non-coding RNA biology but not in direct drug targeting[3]. Please note: For information on the actual mitochondrial NADH dehydrogenase 1 (MT-ND1), refer to ENSG00000198888, not ENSG00000287800[6].

Other names
MT-ND1 pseudogeneND1 pseudogene
02

Biological functions

Other (The pseudogene does not have a protein function; it may have non-coding RNA functions or influence parental gene expression, per research on pseudogenes)
03

Disease associations

Other (No direct disease involvement; however, expression of pseudogenes can modulate parental gene expression or epigenetic marks but not as a therapeutically actionable target)
04

Safety considerations

no therapeutic challenges or safety concerns associated with targeting, as it is not a drug target
05

Biomarkers

not a biomarker for patient selection or efficacy monitoring in clinical practice; however, in research, pseudogene transcription may influence parental gene regulation or serve as a biomarker for studies of epigenetic regulation

Beyond the preview

Go deeper on Mitochondrially encoded NADH dehydrogenase 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded NADH dehydrogenase 1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call